Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update

$MediciNova(MNOV.US)$ Medicinova Announces Data From Phase 1B/2a Clinical Trial of Mn-166 (Ibudilast) in Glioblastoma Patients at the American Society of Clinical Oncology (Asco) Annual Meeting 2024. Was safe and well tolerated.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
11
Translate
Report
1844 Views
Comment
Sign in to post a comment

View more comments...

2290Followers
31Following
29KVisitors
Follow